Crohn's Colitis Professional

APP Biosimilar Education Video Series Module 4

ReachMD Healthcare Image

This series is designed to give advanced practice providers a better understanding of biosimilars as treatment options and how to discuss these options with patients. In this four-module series, APPs will learn how to introduce biosimilars to their patients, discuss initiation of a biologic/biosimilar, answer questions on efficacy compared to their originator drugs and discuss an insurance mandated switch.    

  • Overview

    In Module 4, APPs will learn about insurer-mandated switching to biosimilars and how to effectively communicate with the patient. This module provides tools and resources to support patient switching, explains the nocebo effect, and reinforces health literacy and resources to support patients. 

    Ross M Maltz, MD
    Pediatric Gastroenterologist
    Nationwide Children’s Hospitial, Director of Very Early Onset Inflammatory Bowel Disease Program
    Columbus, OH

    This program made possible in part by:

Facebook Comments


We’re glad to see you’re enjoying Crohn's Colitis Professional…
but how about a more personalized experience?

Register for free